Ottawa, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The oral GLP-1 market is rapidly advancing on a scale, with expectations of accumulating hundreds of millions in revenue between 2025 and 2035. Market ...
Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just one week following the early-January U.S. launch of the oral version of its ...
NVO stock climbed 9.1% after reports of strong first-week U.S. prescriptions for oral Wegovy. Reported data covers retail only and excludes NovoCare, implying actual early oral Wegovy sales may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results